Ma X - Search Results

1

MGAT5/TMEM163 variant is associated with prognosis in ursodeoxycholic acid-treated patients with primary biliary cholangitis.

Wang H, Li Y, Pu X, Liang X, Tang R, Ma X. Wang H, et al. Among authors: ma x. J Gastroenterol. 2024 Jan;59(1):66-74. doi: 10.1007/s00535-023-02045-z. Epub 2023 Oct 16. J Gastroenterol. 2024. PMID: 37845416

2

Epigenetics of Primary Biliary Cholangitis.

Li Y, Tang R, Ma X. Li Y, et al. Among authors: ma x. Adv Exp Med Biol. 2020;1253:259-283. doi: 10.1007/978-981-15-3449-2_10. Adv Exp Med Biol. 2020. PMID: 32445099 Review.

3

A regulatory variant at 19p13.3 is associated with primary biliary cholangitis risk and ARID3A expression.

Li Y, Li Z, Chen R, Lian M, Wang H, Wei Y, You Z, Zhang J, Li B, Li Y, Huang B, Chen Y, Liu Q, Lyu Z, Liang X, Miao Q, Xiao X, Wang Q, Fang J, Shi Y, Liu X, Seldin MF, Gershwin ME, Tang R, Ma X. Li Y, et al. Among authors: ma x. Nat Commun. 2023 Mar 28;14(1):1732. doi: 10.1038/s41467-023-37213-5. Nat Commun. 2023. PMID: 36977669 Free PMC article.

4

Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.

Li Y, Tang R, Leung PSC, Gershwin ME, Ma X. Li Y, et al. Among authors: ma x. Autoimmun Rev. 2017 Sep;16(9):885-896. doi: 10.1016/j.autrev.2017.07.002. Epub 2017 Jul 8. Autoimmun Rev. 2017. PMID: 28698093 Review.

5

[Advances in the treatment of primary biliary cholangitis].

Li YM, Wang QX, Ma X. Li YM, et al. Among authors: ma x. Zhonghua Gan Zang Bing Za Zhi. 2017 Nov 20;25(11):805-809. doi: 10.3760/cma.j.issn.1007-3418.2017.11.002. Zhonghua Gan Zang Bing Za Zhi. 2017. PMID: 29325272 Chinese.

6

Proteomics in Primary Biliary Cholangitis.

Li Y, Tang R, Leung PSC, Gershwin ME, Ma X. Li Y, et al. Among authors: ma x. Methods Mol Biol. 2019;1981:163-173. doi: 10.1007/978-1-4939-9420-5_11. Methods Mol Biol. 2019. PMID: 31016654

7

Cytotoxic KLRG1 expressing lymphocytes invade portal tracts in primary biliary cholangitis.

Li Y, Li B, You Z, Zhang J, Wei Y, Li Y, Chen Y, Huang B, Wang Q, Miao Q, Peng Y, Fang J, Gershwin ME, Tang R, Greenberg SA, Ma X. Li Y, et al. Among authors: ma x. J Autoimmun. 2019 Sep;103:102293. doi: 10.1016/j.jaut.2019.06.004. Epub 2019 Jun 27. J Autoimmun. 2019. PMID: 31255417 Free article. Clinical Trial.

8

Implications of gut microbiota in autoimmune liver diseases.

Qian Q, He W, Tang R, Ma X. Qian Q, et al. Among authors: ma x. Minerva Gastroenterol (Torino). 2023 Mar;69(1):95-106. doi: 10.23736/S2724-5985.21.02860-9. Epub 2021 Apr 1. Minerva Gastroenterol (Torino). 2023. PMID: 33793160 Review.

9

[Expression and clinical significance of interleukin-16 in patients with primary biliary cholangitis].

Liu QY, Li Y, Ma X, Tang RQ. Liu QY, et al. Among authors: ma x. Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):527-532. doi: 10.3760/cma.j.cn501113-20210329-00145. Zhonghua Gan Zang Bing Za Zhi. 2021. PMID: 34225426 Chinese.

10

Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.

Li B, Zhang J, Chen Y, Wang Q, Yan L, Wang R, Wei Y, You Z, Li Y, Miao Q, Xiao X, Lian M, Chen W, Qiu D, Fang J, Gershwin ME, Tang R, Ma X. Li B, et al. Among authors: ma x. Gut Microbes. 2021 Jan-Dec;13(1):1946366. doi: 10.1080/19490976.2021.1946366. Gut Microbes. 2021. PMID: 34437819 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31,958 results

Search Page